newsfilter
← Latest News
GlobeNewswire·

Opus Genetics to Present at Upcoming Investor Conferences in March 2026

RESEARCH TRIANGLE PARK, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (NASDAQ:IRD) ("Opus Genetics" or the "Company"), a clinical-stage biopharmaceutical company developing gene therapies to restore